Magainins: The Frog Skin Peptides That Kill Bacteria, Fungi, and Parasites

What the researchers found

Two closely related 23-amino-acid peptides called magainins were isolated from the skin of the African clawed frog (Xenopus laevis). These peptides kill numerous species of bacteria and fungi at low concentrations, lyse protozoa through osmotic disruption, and are water-soluble and nonhemolytic — meaning they destroy microbes without damaging red blood cells.

Both peptides derive from a common precursor protein, as confirmed by partial cDNA sequencing. They differ by only two amino acid substitutions and are potentially amphiphilic (having both water-loving and fat-loving regions), which likely explains how they interact with microbial membranes.

Why it matters

This 1987 paper is a landmark in antimicrobial peptide research. It was the first to characterize magainins — a discovery that launched an entire field of study into natural antimicrobial peptides as potential alternatives to conventional antibiotics. The finding that a vertebrate animal produces broad-spectrum antimicrobial peptides in its skin opened the door to understanding innate immune defense across species and inspired decades of drug development efforts.

The numbers in context

Two peptides, each 23 amino acids; differ by 2 substitutions; broad-spectrum activity against bacteria, fungi, and protozoa; nonhemolytic at antimicrobial concentrations; derived from common precursor protein

How the study worked

The researchers isolated peptides from the skin of Xenopus laevis frogs using high-pressure liquid chromatography. They characterized two active peptide forms, determined their amino acid sequences, tested antimicrobial activity against multiple bacterial, fungal, and protozoal species, checked for hemolytic toxicity, and obtained partial cDNA sequence of the precursor protein.

Who was studied

Xenopus laevis (African clawed frog) skin; in vitro microbial testing

What this study cannot tell us

This is an in vitro characterization study from 1987. Antimicrobial activity was demonstrated in laboratory conditions, not in living organisms. The mechanism of action was proposed but not directly demonstrated. Clinical applicability to human infections was not tested.

How to read the evidence

This is a foundational laboratory study that characterized a new class of molecules. While it doesn't include clinical or even animal treatment data, its importance lies in the discovery itself — it opened an entirely new field of antimicrobial research.

When this study was published

Published in 1987, this is a seminal paper that launched the modern field of antimicrobial peptide research. Its findings remain highly relevant as the foundation for ongoing work in peptide-based antibiotics.

The bigger picture

This paper is one of the founding studies of the antimicrobial peptide field. The discovery of magainins showed that vertebrates produce their own natural antibiotics, an insight that reshaped our understanding of innate immunity. In the decades since, thousands of antimicrobial peptides have been identified across species, and several have entered clinical development as potential alternatives to conventional antibiotics — especially important as antibiotic resistance grows worldwide.

Questions still open

• Can magainins or their synthetic derivatives be developed into effective drugs for human infections?
• What is the exact mechanism by which these amphiphilic peptides destroy microbial membranes while sparing host cells?
• Do other vertebrate species produce similar skin-based antimicrobial peptides?

Common questions

Read the original research

Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.

Proceedings of the National Academy of Sciences of the United States of America, 84(15), 5449-53

Citation

Zasloff, M. (1987). Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.. Proceedings of the National Academy of Sciences of the United States of America, 84(15), 5449-53.